SIRT6 and pulmonary fibrosis: In terms of energy metabolism, He et al. found that SIRT6 alleviates bleomycin-induced lipotoxicity by encouraging the breakdown of lipids, which raises the energy supply and decreases lipid peroxide levels, thereby slowing the development of pulmonary fibrosis (He et al., 2024b).